As of November 2024, GeneMatrix has a market cap of $39.25M. This makes GeneMatrix the world's 26589th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $35.84M | -13.69% |
2023 | $41.52M | -24.27% |
2022 | $54.83M | -58.16% |
2021 | $131.06M | 86.31% |
2018 | $70.34M | 47.55% |
2017 | $47.68M | -30.23% |
2016 | $68.34M | 58.20% |
2015 | $43.20M | 30.24% |
2014 | $33.17M | 41.31% |
2013 | $23.47M | -50.49% |
2012 | $47.41M | - |